JAN 15, 2018 7:51 AM PST

Is Stress Making You Sick?

WRITTEN BY: Kara Marker

Increased stress - either psychological or allergic - can make the body’s response to disease much more serious. In a new study from Michigan State University, scientists investigate the impact of stress-induced disease when the body lacks a certain immune cell receptor.

"This work is a critical step forward in decoding how stress makes us sick and provides a new target pathway in the mast cell for therapies to improve the quality of life of people suffering from common stress-related diseases,” explained Michigan State’s Adam Moeser.

Mast cells are immune cells involved in both in the innate, or non-specific, and adaptive, or specific, immune response. Additionally, past research has linked them with dilation of blood vessels, creation of new blood vessels, and venom detoxification.

Moeser’s new study involves a stress receptor called corticotropin-releasing factor (CRF1). In response to stress, CRF-1 releases corticotropin, a polypeptide hormone. Ultimately, CRF1 sends signals to mast cells and influences their activity.

“CRF1 tells [mast] cells to release chemical substances that can lead to inflammatory and allergic diseases such as irritable bowel syndrome, asthma, life-threatening food allergies and autoimmune disorders such as lupus,” Moeser said.

The new study tested the histamine response of mice to either psychological stress or allergic stress. Histamine is a compound produced by the body to eliminate allergens like pollen or food proteins. Histamine is present in both normal allergic reactions like sneezing and in more serious reactions that can result from excess stress or a severe allergy. In the case of more serious allergic reaction, sneezing can become trouble breathing, anaphylactic shock, or death.

Researchers tested the response of histamine to stress with two different groups of mice: those with CRF1 receptors intact, and those with mast cells lacking the receptors. For the mice lacking CRF1 receptors, results showed low levels of histamine, a 54 percent reduction in disease when exposed to allergic stress, and a 63 percent disease reduction after exposure to psychological stress.

"This tells us that CRF1 is critically involved in some diseases initiated by these stressors,” Moeser said.

Moser and the rest of the research team hope to apply their new understanding of the relationship between CRF1, mast cells, the histamine response, and allergic reactions to the clinic. Potentially, the could one day identify new ways to treat troublesome allergic diseases such as asthma and irritable bowel syndrome.

The present study was published in the Journal of Leukocyte Biology.

Sources: Michigan State University, Gene ID, DrugBank, News Medical Life Sciences, Frontiers in Immunology

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 12, 2021
Health & Medicine
T-Cell Signature Distinguishes COVID-19 Immunity from Other Respiratory Infections
NOV 12, 2021
T-Cell Signature Distinguishes COVID-19 Immunity from Other Respiratory Infections
COVID-19 is a highly studied disease. It’s caused the most significant influx of research papers in a single year& ...
DEC 11, 2021
Health & Medicine
The Vaccinated Can Still Get Long COVID
DEC 11, 2021
The Vaccinated Can Still Get Long COVID
Those who suffer from long COVID have persistent or new symptoms that weren't present during acute infection with SA ...
JAN 02, 2022
Health & Medicine
COVID Predicted to be Endemic by 2024
JAN 02, 2022
COVID Predicted to be Endemic by 2024
Pfizer executives predict COVID will be endemic as early as 2024. What does COVID's endemicity look like? Much like ...
JAN 13, 2022
Immunology
Gene Unveiled as Missing Link in Antibody Development
JAN 13, 2022
Gene Unveiled as Missing Link in Antibody Development
  Antibodies are a core part of the immune system's pathogen-fighting arsenal, defending the body against bacte ...
JAN 13, 2022
Immunology
Convalescent Plasma Therapy 'Keeps up' With COVID Variants
JAN 13, 2022
Convalescent Plasma Therapy 'Keeps up' With COVID Variants
A recent study has demonstrated that COVID-19 convalescent plasma treatment (or blood from individuals who have recovere ...
JAN 13, 2022
Cancer
An Arthritis Drug Combats Chemoresistance in Pancreatic Cancer
JAN 13, 2022
An Arthritis Drug Combats Chemoresistance in Pancreatic Cancer
The American Cancer Society estimates the lifetime risk of pancreatic cancer at about 1 in 64. Pancreatic duct ...
Loading Comments...